期刊文献+

盐酸吡格列酮治疗代谢综合征36例临床分析 被引量:4

下载PDF
导出
摘要 目的分析盐酸吡格列酮治疗代谢综合征的临术疗效。方法 36例确诊的代谢综合征患者,给予口服盐酸吡格列酮。治疗前及治疗后4周、12周分别测定腰围(WC)、血压(BP)、空腹血糖(FBG)、糖化血红蛋白(HbA_(IC))、三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、空腹胰岛素抵抗指数(HOMA-IR)等指标的变化。结果治疗4周后WC、SBP、DBP、FBG、HbA_(IC)、TG、HDL-C、HOMA-IR均有明显改善,差异有统计学意义(P<0.05),治疗12周后各参数进一步改善,与治疗4周后比较差异有统计学意义(P<0.05)。结论盐酸吡格列酮能有效改善代谢综合征患者的胰岛素抵抗,降低血糖、血压、调节血脂,并有良好安全性。
出处 《疑难病杂志》 CAS 2010年第8期605-606,共2页 Chinese Journal of Difficult and Complicated Cases
  • 相关文献

参考文献9

  • 1Alberti KG,Zimmet PZ.Definition,diagnosis and classification of diabetesmellitus and its complications,part 1:diagnosis and classification of diabetes mellitus provisional report of WHO consultation[J].Diabet Med,1998,15(7):539-553.
  • 2Balkau B,Charles MA.Comment on the provisional report from the WHO consultation.European Group for the Study of Insulin Resistance(E-IR)[J].Diabet Med,1999,16(5):442-443.
  • 3National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel Ⅲ).Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report[J].Circulation,2002,106(25):3143-3421.
  • 4金文胜,潘长玉.国际糖尿病联盟关于代谢综合征定义的全球共识[J].中华内分泌代谢杂志,2005,21(4):412-413. 被引量:157
  • 5杜娟,张素华,任伟,包柄楠,王继旺,陈静,何军,粟绍初.重庆市人群的微量白蛋白尿与代谢综合征的关系调查[J].中华内分泌代谢杂志,2003,19(6):439-441. 被引量:24
  • 6刘辉文,谭万寿,李振兴,颜勇华,杨锋.噻唑烷二酮类药物改善2型糖尿病患者血脂谱的作用及其意义[J].医药导报,2006,25(9):879-881. 被引量:6
  • 7Tsai YS,Kin HJ,Takahashi N,et al.Hypertension and abnomal fat distribution but not insulin resistance in mice with p465L PPAR gamina[J].J Clin Invest,2004,114(2):240-249.
  • 8Betteridge DJ.Effects of pioglitazone on lipid and lipoprotein membolism[J].Diabetes Obes Metab,2007,9(5):640-647.
  • 9陈燕燕,邢小燕,冯凭,纪立农,刘俊江,王瑶,孙瑞华,杨文英,李光伟.罗格列酮对2型糖尿病患者血糖及血压的影响[J].中国糖尿病杂志,2007,15(6):348-351. 被引量:13

二级参考文献27

  • 1李光伟,王金平,李春梅,陈燕燕,杨文英,邢小燕,刘克莉,唐玉龙,黎辉.胰岛素增敏剂罗格列酮抗高血压作用探讨[J].中华内科杂志,2004,43(12):907-910. 被引量:55
  • 2李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 3任艳.微量白蛋白尿与胰岛素抵抗综合征[A].李秀均 主编.胰岛素抵抗综合征[C].北京:人民卫生出版社,2001.156-167.
  • 4Parulkar A A,Pendergras M L,Granda-Ayala R,et al.Nonhypoglycemic effects of thiazolidinedines[J].Ann Intern Med,2001,134(1):61 -71.
  • 5Boden G,Homko C,Mozzoli M,et al.Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients[J].Diabetes,2005,54(3):880-885.
  • 6Tack C J,Smits P,Demacker P N,et al.Troglitazone decreases the proportion of small,dense LDL and increases the resistance of LDL to oxidation in obese subjects[J].Diabetes Care,1998,21 (2):796 -799.
  • 7Teruel T,Hernandez R,Rial E,et al.Rosiglitazone up-regulates lipoprotein lipase,hormone-sensitive lipase and uncoupling protein-1,and down-regulates insulin-induced fatty acid synthase gene expression in brown adipocytes of Wistar rats[J].Diabetologia,2005,48 (11):2011-2017.
  • 8Coort S L,Coumans W A,Bonen A,et al.Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats[J].J Lipid Res,2005,46 (6):1295 -1302.
  • 9Kim H,Haluzik M,Gavrilova O,et al.Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2diabetes[J].Diabetologia,2004,47 (12):2215-2225.
  • 10Wilson-Fritch L,Nicoloro S,Chouinard M,et al.Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone[J].J Clin Invest,2004,114(9):1281-1289.

共引文献195

同被引文献40

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部